|Bid||2.06 x 900|
|Ask||11.50 x 800|
|Day's Range||10.68 - 11.50|
|52 Week Range||2.58 - 16.37|
|Beta (5Y Monthly)||1.68|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 18, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||21.40|
Investors need to pay close attention to Alpine (ALPN) stock based on the movements in the options market lately.
Alpine Immune Sciences Presents Clinical and Preclinical Oncology Program Updates at AACR Virtual Annual Meeting I
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...